User menu

Selective destruction of nigrostriatal dopaminergic neurons does not alter [H-3]-ryanodine binding in rat striatum

Bibliographic reference Noël, F. ; Geurts, M ; Maloteaux, Jean-Marie. Selective destruction of nigrostriatal dopaminergic neurons does not alter [H-3]-ryanodine binding in rat striatum. In: Brazilian Journal of Medical and Biological Research, Vol. 33, no. 2, p. 237-240 (2000)
Permanent URL
  1. Korczyn AD, Parkinson's disease (1995)
  2. MILLER R, The control of neuronal Ca2+ homeostasis, 10.1016/0301-0082(91)90028-y
  3. Pessah Isaac N., Lynch Carl, Gronert Gerald A., Complex Pharmacology of Malignant Hyperthermia : , 10.1097/00000542-199606000-00001
  4. Ward A, Drugs, 32, 130 (1986)
  5. Toshio Ohta, Shigeo Ito, Akira Ohga, Inhibitory action of dantrolene on Ca-induced Ca2+ release from sarcoplasmic reticulum in guinea pig skeletal muscle, 10.1016/0014-2999(90)94788-y
  6. Nisijima Koichi, Ishiguro Takeo, Does dantrolene influence central dopamine and serotonin metabolism in the neuroleptic malignant syndrome? A retrospective study, 10.1016/0006-3223(93)90277-k
  7. Oyamada Takahiro, Hayashi Teruo, Kagaya Ariyuki, Yokota Norio, Yamawaki Shigeto, Effect of dantrolene on K+- and caffeine-induced dopamine release in rat striatum assessed by in vivo microdialysis, 10.1016/s0197-0186(97)00068-5
  8. Hökfelt Tomas, Ungerstedt Urban, Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: An electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system, 10.1016/0006-8993(73)90791-9
  9. Ungerstedt Urban, 6-hydroxy-dopamine induced degeneration of central monoamine neurons, 10.1016/0014-2999(68)90164-7
  10. Paxinos G (1986)
  11. Bradford Marion M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, 10.1016/0003-2697(76)90527-3
  12. Padua Rodolfo A., Wan Weihua, Nagy James I., Geiger Jonathan D., [3H]Ryanodine binding sites in rat brain demonstrated by membrane binding and autoradiography, 10.1016/0006-8993(91)91007-n
  13. Silva Cláudia L.M, Cunha Valéria M.N, Mendonça-Silva Dayde L, Noël François, Evidence for ryanodine receptors in Schistosoma mansoni, 10.1016/s0006-2952(98)00219-6
  14. Maloteaux Jean-Marie, Vanisberg Marie-Agnes, Laterre Christian, Javoy-Agid France, Agid Yves, Laduron Pierre M., [3H]GBR 12935 binding to dopamine uptake sites: subcellular localizatio and reduction in Parkinson's disease and progressive supranuclear palsy, 10.1016/0014-2999(88)90278-6
  15. Richfield Eric K., Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics, 10.1016/0006-8993(91)90486-f
  16. Quirion R., Chiueh C.C., Everist H.D., Pert A., Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals, 10.1016/0006-8993(85)91542-2
  17. Martone Maryann E, Alba Saul A, Edelman Victoria M, Airey Judith A, Ellisman Mark H, Distribution of inositol-1,4,5-trisphosphate and ryanodine receptors in rat neostriatum, 10.1016/s0006-8993(96)01430-8
  18. Ogawa Y., Properties of Ryr3 Ryanodine Receptor Isoform in Mammalian Brain, 10.1074/jbc.271.9.5079
  19. Wolters EC, Dopamine agonist monotherapy in Parkinson's disease (1994)